COVID‐19 vaccine‐induced vasculitis in a patient with sarcoidosis: A case report

A 55‐year‐old lady with a nine‐year history of controlled sarcoidosis developed vasculitis after Sinopharm COVID‐19 vaccine (BBIBP‐ CorV). She was ultimately diagnosed with mononeuritis multiplex based on EMG‐NCV findings and administered methylprednisolone and cyclophosphamide pulse therapy for 5 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmanian, Ehsan, Alikhani, Majid, Loghman, Maryam, Beikmohamadi Hezaveh, Sara, Zangeneh, Saba, Shahriarirad, Reza, Faezi, Seyedeh Tahereh, Nejadhosseinian, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718919/
https://www.ncbi.nlm.nih.gov/pubmed/36478972
http://dx.doi.org/10.1002/ccr3.6501
Descripción
Sumario:A 55‐year‐old lady with a nine‐year history of controlled sarcoidosis developed vasculitis after Sinopharm COVID‐19 vaccine (BBIBP‐ CorV). She was ultimately diagnosed with mononeuritis multiplex based on EMG‐NCV findings and administered methylprednisolone and cyclophosphamide pulse therapy for 5 days, and then continue with prednisolone and a monthly pulse of cyclophosphamide.

Ejemplares similares